Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,556 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.
Hillemanns P, Zikan M, Forget F, Denys HG, Baurain JF, Rob L, Woelber L, Blecharz P, Bidzinski M, Chovanec J, Marmé F, Link T, Dannecker C, Rosholm A, Berg KCG, Oliveri RS, Lindemann K; VB C-02 investigators; VB C-02 study. Hillemanns P, et al. J Immunother Cancer. 2025 Jan 7;13(1):e010827. doi: 10.1136/jitc-2024-010827. J Immunother Cancer. 2025. PMID: 39773564 Free article. Clinical Trial.
A standardized care pathway increases optimal dialysis starts.
Marcus RG, Miller DM, Nathanson BH, Eckhardt D, Henry S, Kwon K, Sharma R, Vakharia N. Marcus RG, et al. Among authors: henry s. Am J Manag Care. 2024 Dec 1;30(12):e345-e351. doi: 10.37765/ajmc.2024.89642. Am J Manag Care. 2024. PMID: 39745500 Free article.
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nufel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Among authors: henry s. Cancer Immunol Immunother. 2024 Dec 30;74(1):32. doi: 10.1007/s00262-024-03873-5. Cancer Immunol Immunother. 2024. PMID: 39738642 Free PMC article. No abstract available.
Some Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System.
Shilova N, Nokel A, Lipatnikov A, Khasbiullina N, Knirel Y, Baidakova L, Tuzikov A, Khaidukov S, Obukhova P, Henry S, Shoibonov B, Salimov E, Rieben R, Bovin N. Shilova N, et al. Among authors: henry s. Antibodies (Basel). 2024 Dec 23;13(4):105. doi: 10.3390/antib13040105. Antibodies (Basel). 2024. PMID: 39727488 Free PMC article.
1,556 results